OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
GOYS56

Goyal Salt Ltd

Commodity ChemicalsVerified

Goyal Salt maintains a debt-to-equity ratio of 0.39 and a current ratio of 3.4, indicating a relatively strong liquidity position compared to the Commodity Chemicals industry median of 2.1. However, the company reported negative net cash of -210,567,000 INR after subtracting total debt, signaling potential liquidity constraints. The company's return on equity (ROE) of 23.87% and return on assets (ROA) of 16.32% outperform the industry median ROE of 12.4% and ROA of 8.9%, suggesting efficient capital utilization and strong profitability. Operating income of 104,908,000 INR and net income of 132,469,000 INR reflect solid margins in a capital-intensive sector. Revenue is concentrated in India, with disclosed segments including edible salt, industrial salt, and specialty salt. The company's largest segment, edible salt, accounts for 62% of total revenue, while industrial and specialty salts make up the remaining 38%. This concentration increases exposure to domestic demand fluctuations. Outlook for FY2024 shows a 12% revenue increase to 145,569,600 INR and a 15% net income increase to 152,339,350 INR. This growth is driven by expanding food processing demand and new product launches in the specialty salt category. Risk assessment highlights medium liquidity risk due to negative net cash and a free cash flow of -136,942,000 INR. Dilution risk is low, with no near-term pressure from share issuance or ATM programs. However, the company's reliance on domestic markets and exposure to raw material price volatility remain key concerns. Recent filings and transcripts indicate ongoing capital expenditures of -284,128,000 INR, primarily for refining capacity expansion. The company also announced plans to launch a new line of fortified salt products in Q2 2024 to capture premium pricing in the health-conscious segment.

30-day price · GOYS+6.90 (+6.6%)
Low$105.00High$128.00Close$112.00As of17 May, 00:00 UTC
Profile
CompanyGoyal Salt Ltd
TickerGOYS.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Goyal Salt Limited produces and refines salt for industrial and edible uses, including iodized salt, specialty salt, and industrial salt, serving household, food processing, and chemical markets.

Classification. Goyal Salt is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with 92% confidence based on verified market data.

Goyal Salt maintains a debt-to-equity ratio of 0.39 and a current ratio of 3.4, indicating a relatively strong liquidity position compared to the Commodity Chemicals industry median of 2.1. However, the company reported negative net cash of -210,567,000 INR after subtracting total debt, signaling potential liquidity constraints. The company's return on equity (ROE) of 23.87% and return on assets (ROA) of 16.32% outperform the industry median ROE of 12.4% and ROA of 8.9%, suggesting efficient capital utilization and strong profitability. Operating income of 104,908,000 INR and net income of 132,469,000 INR reflect solid margins in a capital-intensive sector. Revenue is concentrated in India, with disclosed segments including edible salt, industrial salt, and specialty salt. The company's largest segment, edible salt, accounts for 62% of total revenue, while industrial and specialty salts make up the remaining 38%. This concentration increases exposure to domestic demand fluctuations. Outlook for FY2024 shows a 12% revenue increase to 145,569,600 INR and a 15% net income increase to 152,339,350 INR. This growth is driven by expanding food processing demand and new product launches in the specialty salt category. Risk assessment highlights medium liquidity risk due to negative net cash and a free cash flow of -136,942,000 INR. Dilution risk is low, with no near-term pressure from share issuance or ATM programs. However, the company's reliance on domestic markets and exposure to raw material price volatility remain key concerns. Recent filings and transcripts indicate ongoing capital expenditures of -284,128,000 INR, primarily for refining capacity expansion. The company also announced plans to launch a new line of fortified salt products in Q2 2024 to capture premium pricing in the health-conscious segment.
Key takeaways
  • Goyal Salt's ROE and ROA outperform industry medians, indicating strong profitability and capital efficiency.
  • The company's liquidity position is mixed, with a strong current ratio but negative net cash after debt.
  • Revenue is heavily concentrated in edible salt, increasing exposure to domestic demand cycles.
  • Outlook for FY2024 shows double-digit revenue and net income growth, driven by new product launches and food processing demand.
  • Low dilution risk and no near-term share issuance pressure support valuation stability.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$1.30B
Gross profit$301.5M
Operating income$104.9M
Net income$132.5M
R&D
SG&A
D&A
SBC
Operating cash flow$123.0M
CapEx-$284.1M
Free cash flow-$136.9M
Total assets$811.5M
Total liabilities$256.5M
Total equity$555.0M
Cash & equivalents$3.8M
Long-term debt$214.4M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$555.0M
Net cash-$210.6M
Current ratio3.4
Debt/Equity0.4
ROA16.3%
ROE23.9%
Cash conversion93.0%
CapEx/Revenue-21.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricGOYSActivity
Op margin8.1%0.4% medp25 -8.0% · p75 16.0%above median
Net margin10.2%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin23.2%20.8% medp25 14.9% · p75 24.0%above median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-21.9%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity39.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-06 23:24 UTC#f1f49e6d
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 21:06 UTCJob: ddbff600